Trana Discovery is an anti-infective drug discovery technology company that helps its partners find new classes of drugs for the treatment of bacterial, viral, and fungal infectious diseases. Our proprietary assays identify compounds that work through a unique mechanism of action: inhibition of the target pathogen’s ability to use transfer RNA (tRNA) essential for propagation.

The use of high-throughput screening assays developed by Trana Discovery will reduce the cost and time for drug discovery. Our company provides licensing opportunities for exclusive rights to new drug classes.
Learn how HIV uses tRNA during replication
Learn how our technology can add value to your company
View company information & technology information
Read about the NEW Trana HIV 201 Assay




  • New Trana HIV 201 Assay screens 50,000 compounds per day more >>

  • Proprietary and patented technology

  • Actively seeking licensing partners for HIV assay

  • Contact us at: info@tranadiscovery.com
    1-866-390-3452 (toll free)
    1-919-342-6192 (int'l)



June 2009: Trana Discovery Forms Scientific Advisory Board; Taps Pharmaceutical Industry Veteran Mike Ossi as Chairperson

May 2009: Trana Discovery Featured on Radio in Vivo

More news>

 

• HIV (cause of AIDS)
Staphylococcus aureus including MRSA
• Multi-drug resistant tuberculosis
• Malaria and other diseases of the developing world
• Biodefense-related infectious diseases


Copyright © 2009 Trana Discovery, Inc. All rights reserved
Home | About Us | Technology | Assays | News | Contact | Privacy Policy